Application of biomimetic surfaces and 3D culture technology to study the role of extracellular matrix interactions in neurite outgrowth and inhibition
Source abstract
Abstract
The microenvironment that cells experience during in vitro culture can often be far removed from the native environment they are exposed to in vivo. To recreate the physiological environment that developing neurites experience in vivo, we combine a well-established model of human neurite development with, functionalisation of both 2D and 3D growth substrates with specific extracellular matrix (ECM) derived motifs displayed on engineered scaffold proteins. Functionalisation of growth substrates provides biochemical signals more reminiscent of the in vivo environment and the combination of this technology with 3D cell culture techniques, further recapitulates the native cellular environment by providing a more physiologically relevant geometry for neurites to develop. This biomaterials approach was used to study interactions between the ECM and developing neurites, along with the identification of specific motifs able to enhance neuritogenesis within this model. Furthermore, this technology was employed to study the process of neurite inhibition that has a detrimental effect on neuronal connectivity following injury to the central nervous system (CNS). Growth substrates were functionalised with inhibitory peptides released from damaged myelin within the injured spinal cord (Nogo & OMgp). This model was then utilised to study the underlying molecular mechanisms that govern neurite inhibition in addition to potential mechanisms of recovery.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nerve injury and regeneration · Neurogenesis and neuroplasticity mechanisms · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (90)
Show source-provided references
1. Breaking the neuronal sphere: regulation of the actin cytoskeleton in neuritogenesis10.1038/nrn918 ↗
2. Protein kinases: master regulators of neuritogenesis and therapeutic targets for axon regeneration10.1007/s00018-019-03336-6 ↗
3. Modeling tissue morphogenesis and cancer in 3D10.1016/j.cell.2007.08.006 ↗
4. Taking cell-matrix adhesions to the third dimension10.1126/science.1064829 ↗
5. Regulation of axonal outgrowth and pathfinding by integrin-ECM interactions10.1002/dneu.20931 ↗
6. Advances in 3D cell culture technologies enabling tissue-like structures to be created in vitro10.1111/joa.12257 ↗
7. Modeling physiological events in 2D vs. 3D cell culture10.1152/physiol.00036.2016 ↗
8. 2D and 3D cell cultures - a comparison of different types of cancer cell cultures
9. Is it time to start transitioning from 2D to 3D cell culture?10.3389/fmolb.2020.00033 ↗
10. Effect of chondroitin sulfate proteoglycans on neuronal cell adhesion, spreading and neurite growth in culture10.4103/1673-5374.226398 ↗
11. Inhibition and enhancement of neural regeneration by chondroitin sulfate proteoglycans10.4103/1673-5374.206630 ↗
12. Extracellular matrix and traumatic brain injury10.1002/jnr.24151 ↗
13. Crosstalk between glia, extracellular matrix and neurons10.1016/j.brainresbull.2017.03.003 ↗
14. A tenascin-C mimetic peptide amphiphile nanofiber gel promotes neurite outgrowth and cell migration of neurosphere-derived cells10.1016/j.actbio.2016.04.010 ↗
15. Nerve guidance by a decellularized fibroblast extracellular matrix10.1016/j.matbio.2016.08.011 ↗
16. Guidance of neurite outgrowth by pathways of substratum-adsorbed laminin10.1002/jnr.490130115 ↗
17. Exploring the effects of electrospun fiber surface nanotopography on neurite outgrowth and branching in neuron cultures10.1371/journal.pone.0211731 ↗
18. Biofunctionalized peptide-based hydrogels provide permissive scaffolds to attract neurite outgrowth from spiral ganglion neurons10.1016/j.colsurfb.2016.10.003 ↗
19. Biofunctionalized silk fibroin nanofibers for directional and long neurite outgrowth10.1063/1.5120738 ↗
20. Increased neuritogenesis on ternary nanofiber matrices of PLCL and laminin decorated with black phosphorus10.1016/j.jiec.2020.09.009 ↗
21. Structure-activity study of a laminin α1 chain active peptide segment Ile-Lys-Val-Ala-Val (IKVAV)10.1016/0014-5793(95)00475-O ↗
22. Growth cones turn and migrate up an immobilized gradient of the laminin IKVAV peptide10.1002/neu.20075 ↗
23. A synthetic peptide containing the IKVAV sequence from the a chain of laminin mediates cell attachment, migration, and neurite outgrowth10.1016/S0021-9258(18)71604-9 ↗
24. Beta-amyloid precursor protein binds to the neurite-promoting IKVAV site of laminin10.1073/pnas.90.21.10150 ↗
25. Bifunctional hydrogels containing the laminin motif IKVAV promote neurogenesis10.1016/j.stemcr.2017.09.002 ↗
26. Manipulation of extracellular matrix remodeling and neurite extension by mouse embryonic stem cells using IKVAV and LRE peptide tethering in hyaluronic acid matrices10.1021/acs.biomac.9b00578 ↗
27. Identification of a neurite outgrowth-promoting domain of laminin using synthetic peptides10.1016/0014-5793(89)81180-9 ↗
28. Focal adhesion kinase promotes integrin adhesion dynamics necessary for chemotropic turning of nerve growth cones10.1523/JNEUROSCI.2381-11.2011 ↗
29. Focal adhesion kinase modulates Cdc42 activity downstream of positive and negative axon guidance cues
30. Environmental elasticity regulates cell-type specific RHOA signaling and neuritogenesis of human neurons10.1016/j.stemcr.2019.10.008 ↗
31. Perturbations in RhoA signalling cause altered migration and impaired neuritogenesis in human iPSC-derived neural cells with PARK2 mutation10.1016/j.nbd.2019.104581 ↗
32. The bright side of the glial scar in CNS repair10.1038/nrn2591 ↗
33. The glial scar and central nervous system repair10.1016/S0361-9230(99)00072-6 ↗
34. Glial inhibition of CNS axon regeneration10.1038/nrn1956 ↗
35. Regeneration beyond the glial scar10.1038/nrn1326 ↗
36. Nogo domains and a Nogo receptor: implications for axon regeneration10.1016/S0896-6273(01)00258-6 ↗
37. Functions of Nogo proteins and their receptors in the nervous system10.1038/nrn2936 ↗
38. Characterization of myelin ligand complexes with neuronal Nogo-66 receptor family members10.1074/jbc.M609797200 ↗
39. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor10.1126/science.1073031 ↗
40. p75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp10.1038/nature01176 ↗
41. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac110.1523/JNEUROSCI.22-23-10368.2002 ↗
42. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex10.1038/nn1188 ↗
43. The Nogo-66 receptor: focusing myelin inhibition of axon regeneration10.1016/S0166-2236(03)00062-6 ↗
44. The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review10.1023/A:1023941421781 ↗
45. A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors10.1016/j.neuron.2004.12.040 ↗
46. A p75NTR and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein10.1038/nn975 ↗
47. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth10.1038/nature00867 ↗
48. Nogos and the Nogo-66 receptor: factors inhibiting CNS neuron regeneration10.1002/jnr.10134 ↗
49. A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors10.1016/j.neuron.2004.12.040 ↗
50. Structure and reactivity of adsorbed fibronectin films on mica10.1529/biophysj.107.109819 ↗
51. Self-assembling layers created by membrane proteins on gold10.1042/BST0350522 ↗
52. A manufacturable surface-biology platform for nano applications; cell culture, analyte detection, diagnostics sensors10.1089/ind.2005.1.185 ↗
53. Neural differentiation regulated by biomimetic surfaces presenting motifs of extracellular matrix proteins10.1002/jbm.a.32585 ↗
54. Promoting differentiation of cultured myoblasts using biomimetic surfaces that present alpha-laminin-2 peptides10.1007/s10616-016-0006-y ↗
55. Enhanced cell attachment using a novel cell culture surface presenting functional domains from extracellular matrix proteins10.1007/s10616-007-9119-7 ↗
56. K.E. Clarke D.M. Tams A.P. Henderson M.F. Roger A. Whiting S.A. Przyborski A robust and reproducible human pluripotent stem cell derived model of neurite outgrowth in a three-dimensional culture system and its application to study neurite inhibition, Neurochem. Int. (n.d.). doi:10.1016/j.neuint.2016.12.009.10.1016/j.neuint.2016.12.009 ↗
57. Dose-dependent beneficial and detrimental effects of ROCK inhibitor Y27632 on axonal sprouting and functional recovery after rat spinal cord injury10.1016/j.expneurol.2005.08.011 ↗
58. The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar10.1016/S1044-7431(02)00035-0 ↗
59. Inhibition of rho kinase (ROCK) increases neurite outgrowth on chondroitin sulphate proteoglycan in vitro and axonal regeneration in the adult optic nerve in vivo10.1111/j.1471-4159.2007.04756.x ↗
60. Rho kinase (ROCK) inhibitors10.1097/FJC.0b013e318070d1bd ↗
61. Rho-ROCK inhibition in the treatment of spinal cord injury10.1016/j.wneu.2013.01.009 ↗
62. Axon growth inhibition by RhoA/ROCK in the central nervous system10.3389/fnins.2014.00338 ↗
63. Small-molecule-induced rho-inhibition: NSAIDs after spinal cord injury10.1007/s00441-012-1334-7 ↗
64. Nonsteroidal anti-inflammatory drugs promote axon regeneration via RhoA inhibition10.1523/JNEUROSCI.4353-06.2007 ↗
65. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury10.1523/JNEUROSCI.23-10-04219.2003 ↗
66. Nogo-66 receptor antagonist peptide (NEP1-40) administration promotes functional recovery and axonal growth after lateral funiculus injury in the adult rat10.1177/1545968307308550 ↗
67. ROCK inhibition with Y27632 activates astrocytes and increases their expression of neurite growth-inhibitory chondroitin sulfate proteoglycans10.1002/glia.20466 ↗
68. Rho signaling pathway targeted to promote spinal cord repair10.1523/JNEUROSCI.22-15-06570.2002 ↗
69. Role of rho kinase pathway in chondroitin sulfate proteoglycan-mediated inhibition of neurite outgrowth in PC12 cells10.1002/jnr.21671 ↗
70. Laminin peptide YIGSR and its receptor regulate sensory axonal response to the chemoattractive guidance cue in the chick embryo10.1002/jnr.21868 ↗
71. A laminin and nerve growth factor-laden three-dimensional scaffold for enhanced neurite extension10.1089/ten.1999.5.291 ↗
72. Peptide-modified alginate surfaces as a growth permissive substrate for neurite outgrowth10.1002/jbm.a.30103 ↗
73. Neuronal cell attachment to fluorinated ethylene propylene films with covalently immobilized laminin oligopeptides YIGSR and IKVAV. II10.1002/jbm.820290614 ↗
74. Antibodies directed against the β1-integrin subunit and peptides containing the IKVAV sequence of laminin perturb neurite outgrowth of peripheral neurons on immature spinal cord substrata10.1016/0306-4522(95)00447-5 ↗
75. Aligned neurite outgrowth and directed cell migration in self-assembled monodomain gels10.1016/j.biomaterials.2013.09.077 ↗
76. Laminin oligopeptide derivatized agarose gels allow three-dimensional neurite extension in vitro10.1002/jnr.490410409 ↗
77. Regenerative therapies for central nervous system diseases: a biomaterials approach10.1038/npp.2013.237 ↗
78. Identification of cell binding sites in the laminin alpha5-chain G domain10.1006/excr.2002.5540 ↗
79. Screening of integrin-binding peptides from the laminin α4 and α5 chain G domain peptide library10.1016/j.abb.2012.02.017 ↗
80. Identification of cell binding sequences in mouse laminin γ1 chain by systematic peptide screening10.1074/jbc.272.51.32198 ↗
81. Nerve regeneration in the peripheral and central nervous systems10.1113/JP270898 ↗
82. Spinal cord injury: a review of current therapy, future treatments, and basic science frontiers10.1007/s11064-013-0991-6 ↗
83. Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration10.1002/glia.10315 ↗
84. Ephrin-B3 is a myelin-based inhibitor of neurite outgrowth10.1073/pnas.0504021102 ↗
85. A possible role of RhoA/Rho-kinase in experimental spinal cord injury in rat10.1016/S0006-8993(02)03717-4 ↗
86. Rho kinase inhibition enhances axonal regeneration in the injured CNS10.1523/JNEUROSCI.23-04-01416.2003 ↗
87. RhoA/Rho kinase in spinal cord injury10.4103/1673-5374.169601 ↗
88. Synergistic effects of bone marrow stromal cells and a rho kinase (ROCK) inhibitor, Fasudil on axon regeneration in rat spinal cord injury10.1111/j.1440-1789.2009.01077.x ↗
89. Rho kinase, a promising drug target for neurological disorders10.1038/nrd1719 ↗
90. Modulation of Rho GTPase activity alleviates chondroitin sulfate proteoglycan-dependent inhibition of neurite extension10.1002/jnr.20161 ↗